![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Celera Corp. Securities Litigation: UNITED STATES DISTRICT COURTNORTHERN DISTRICT OF...
Quest Diagnostics Successfully Completes Acquisition of Celera PR Newswire MADISON, N.J., May 17, 2011 MADISON, N.J., May 17, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the...
Quest Diagnostics Inc. (DGX) plans to complete its deal for genetics-diagnostics test developer Celera Corp. (CRA) through a short-form merger, as the company announced that it held 61% of...
Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger PR Newswire MADISON, N.J., May 11, 2011...
Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera Offer Concludes at 5 p.m. Tomorrow, Tuesday, May 10th PR Newswire MADISON, N.J., May 9, 2011...
Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera PR Newswire MADISON, N.J., May 4, 2011 MADISON, N.J., May 4, 2011...
Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today Over 52% of Fully-Diluted Shares Tendered to Date, Including Guaranteed Shares PR Newswire MADISON, N.J., May...
The announcement of Quest Diagnostics’ (DGX) first quarter of fiscal 2011 results as on April 20, 2011, has triggered analysts to revise estimates downwards. Previous quarter...
Leading lab-testing company Laboratory Corporation of America Holdings (LH) reported adjusted EPS of $1.52 (excluding amortization, restructuring and other special charges) for the first quarter...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions